[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100614013":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":15,"locations":25,"responsibleParty":39,"collaborators":41,"id":45,"slug":46,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":49,"acronym":10,"eligibilityCriteria":50,"healthyVolunteers":47,"sex":51,"minAge":52,"maxAge":10,"enrollmentInfo":53,"targetDuration":56,"studyType":57,"phases":10,"briefSummary":58,"conditions":59,"keywords":63,"overallStatus":27,"whyStopped":10,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":77},{"fullName":5,"class":6},"Hospital at Home AG","INDUSTRY",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"Hospital at Home Group",null,"100 participants treated in hospital at home",{"label":13,"type":10,"description":14,"interventionNames":10},"Regular hospital group\u002F\"Brick and mortar group\"","100 participants treated in the hospital",[16,21],{"name":17,"role":18,"phone":19,"phoneExt":10,"email":20},"Kilian Braendle, Dr. med.","CONTACT","+41444553304","kilian.braendle@hospitalathome.ch",{"name":22,"role":18,"phone":23,"phoneExt":10,"email":24},"Natascha Furrer, Coordinator","+41443553300","natascha.furrer@hospitalathome.ch",[26],{"facility":5,"status":27,"city":28,"state":29,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":10},"RECRUITING","Zollikon","Canton of Zurich","8702","Switzerland","CH",{"type":34,"coordinates":35},"Point",[36,37],8.57407,47.34019,{"lat":37,"lon":36},{"type":40,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[42],{"name":43,"class":44},"Klinik Hirslanden, Zurich","OTHER","100614013","hospital-at-home-versus-inpatient-care-costs-and-effectiveness-100614013",false,"NCT07274072","Hospital at Home Versus Inpatient Care: Costs and Effectiveness","Inclusion Criteria:\n\n* Inpatients in the hospital or patients in Hospital at Home care\n* Age ≥ 18 years\n* Admission due to a typical Hospital at Home diagnosis (mild to moderate inflammatory and infectious diseases of the lungs, urinary tract, gastrointestinal tract, heart, and skin; exacerbated chronic obstructive pulmonary disease; exacerbation of chronic heart failure; wounds; bleeding\u002Fanemia; dehydration; deterioration of general condition in multimorbid patients; infection-related complications in oncological patients; psychiatric problems including delirium; metabolic or autoimmune diseases; orthopedic patients; pain exacerbations of any cause; palliative patients up to and including terminal situations)\n* Patients without severe cognitive impairment or dysfunction who are capable of providing informed consent and\u002For completing the questionnaire\n* Patients with sufficient proficiency in written and spoken German and\u002For English\n\nExclusion Criteria:\n\n* Inpatient admission for other reasons\n* Refusal to provide informed consent","ALL","18 Years",{"count":54,"type":55},200,"ESTIMATED","1 Day","OBSERVATIONAL","Background and Objectives Hospital at Home (HaH) delivers hospital-level treatment to acutely ill patients in their own homes, including daily medical and nursing visits, infusions, physiotherapy, and diagnostics. It bridges inpatient and outpatient care, working closely with hospitals, office-based physicians, home care services (Spitex), and therapy providers.\n\nThere are two main pathways:\n\nAdmission Avoidance: stable patients requiring hospitalization are admitted directly to HaH instead of an inpatient ward.\n\nEarly Supported Discharge: patients treated in hospital are discharged earlier than usual and transferred to HaH.\n\nEvidence International studies show HaH to be safe and effective. Reviews report comparable mortality and rehospitalization, shorter hospital stays, and cost advantages. Admission avoidance is linked to trends toward lower mortality and costs. Research showed similar mortality but fewer rehospitalizations, longer treatment duration, and reduced risks of institutionalization, depression, and anxiety. HaH patients were older, with reduced daily living activities, yet care costs were on average USD 5,054 lower than inpatient care.\n\nIn Switzerland, the mean hospital stay in 2019 was 8 days (acute somatic: 5.2; psychiatry: 33.5).\n\nStudy Hypotheses\n\nHaH can be delivered at equal or lower cost than regular hospitalization.\n\nHaH care is safe, with few complications, and yields high patient satisfaction.\n\nStudy Objective To demonstrate that hospital-equivalent home treatment of acutely ill patients is effective, appropriate, cost-efficient (according to Swiss WZW criteria), safe, and associated with high satisfaction and low complication rates compared with inpatient care.\n\nEndpoints\n\nPrimary: Costs - HaH vs. inpatient care at Hirslanden Clinic, using REKOLE® cost accounting.\n\nSecondary: Mortality, therapy type, monitoring, diagnostics, rehospitalization, complications, satisfaction, patient-reported outcomes, length of stay, referrals to nursing homes, follow-up after discharge, ED visits, rehabilitation referrals, and home care type.",[60,61,62],"Costs and Cost Analysis","Effectiveness","Patient Satisfaction",[64,65,66,67],"hospital at home","costs","clinical outcome","patient satisfaction","2025-12-09",{"date":70,"type":71},"2025-12-10","ACTUAL",{"date":73,"type":71},"2025-09-01",{"date":75,"type":55},"2026-08-31",{"name":5,"class":6},1]